Suite 1300
Salt Lake City, UT 84111
Block-1 3rd Floor, Perungudi Bypass Rd, Perungudi,
Chennai - 600096
MGR Main Rd,
Perungudi, Chennai - 600096
Villupuram,
Tamil Nadu – 605602
REMS Compliance Billing
REMS Program Billing Built for the FDA-Required Workflow Most Pharmacy Operations Bolt On Reactively
End-to-end Risk Evaluation and Mitigation Strategy (REMS) program billing — REMS enrollment verification, dispensing documentation, ETASU (Elements to Assure Safe Use) compliance, and the regulatory discipline FDA-required REMS programs actually demand from specialty pharmacy operations.
99%+
REMS Compliance Accuracy
95%+
Enrollment Verification Accuracy
100%
ETASU Documentation Capture
The Reality
Why REMS compliance is the regulatory layer specialty pharmacy operations most often treat as an afterthought?
Risk Evaluation and Mitigation Strategy (REMS) programs are FDA-required risk management plans for drugs with significant safety concerns. Many of the highest-cost specialty drugs operate under REMS — including iPLEDGE for isotretinoin, REMS programs for clozapine, thalidomide-class drugs,
transmucosal immediate-release fentanyl (TIRF), and others. Dispensing a REMS-required drug without proper enrollment verification, ETASU compliance, and documentation creates regulatory exposure, claim rejection risk, and patient safety implications. Specialty pharmacy operations that bolt REMS compliance onto generic dispensing workflow absorb compliance and revenue risk simultaneously.
Program-Specific ETASU Requirements
Each REMS program operates different Elements to Assure Safe Use (ETASU) — patient enrollment, prescriber certification, pharmacy certification, dispensing restrictions, monitoring requirements, lab verification, distribution channel restrictions, and documentation. Generic specialty pharmacy workflow can't navigate program-specific ETASU variability.
Enrollment Verification at Dispensing
REMS programs require pre-dispensing verification of patient enrollment, prescriber certification, and pharmacy certification. Dispensing without verified enrollment creates regulatory exposure under FDA enforcement. Generic specialty pharmacy operations frequently treat enrollment verification as a soft check rather than a hard pre-dispensing gate.
Lab and Monitoring Documentation
Many REMS programs (iPLEDGE, clozapine REMS, others) require pre-dispensing lab verification — pregnancy tests, ANC monitoring, liver function tests. Documentation of these requirements must align with dispensing timing, and failures create both compliance exposure and adherence interruptions for patients.
Distribution Channel Restrictions
Some REMS programs restrict distribution to specific pharmacy networks or require specific contracts with manufacturers. Specialty pharmacies operating outside these channels can't dispense REMS-restricted drugs, and operations that don't actively maintain distribution channel access lose patient access to therapy.
Documentation Burden at Specialty Volume
REMS documentation requirements multiplied across hundreds or thousands of REMS-program patient encounters annually become substantial operational burden. Manual documentation processes break down at specialty scale, and documentation gaps create compliance findings during FDA inspections
REMS Program Changes
FDA regularly modifies REMS program requirements — adding monitoring requirements, changing enrollment workflows, adjusting prescriber certification standards. Specialty pharmacies running on outdated REMS protocols face systematic compliance risk on the requirements that have changed.
Our approach
We run REMS compliance as standing specialty pharmacy capability with program-specific discipline
AnnexMed runs REMS compliance billing as dedicated specialty pharmacy capability — with program-specific ETASU compliance workflow, pre-dispensing enrollment verification, lab and monitoring documentation integration, distribution channel access maintenance, and program intelligence updates tracking FDA modifications. REMS compliance becomes operational discipline that protects regulatory standing while preserving patient access.
We serve specialty pharmacies, infusion centers, home infusion providers, and hospital outpatient pharmacies dispensing REMS-program drugs — iPLEDGE-restricted isotretinoin, clozapine REMS, thalidomide-class REMS (Thalomid, Revlimid, Pomalyst), TIRF REMS opioids, ROZLYTREK, and other REMS-restricted specialty therapies. Our team manages REMS compliance across the full universe of active REMS programs with program-specific protocols and ETASU documentation infrastructure.
Recent client results
100%
ETASU Documentation Compliance
Pre-Dispensing
Enrollment Verification
Gate
All Active
REMS Programs
Covered
How we support you
End-to-End compliance billing operation
AnnexMed runs REMS compliance billing as a three-stage operation — pre-dispensing enrollment and ETASU verification, dispensing documentation and lab integration, and program intelligence with distribution channel maintenance — so REMS compliance operates as standing discipline rather than reactive workflow that breaks under FDA inspection.
Pre-Dispensing Verification
Hard regulatory gate
- Patient REMS enrollment verification
- Prescriber certification verification
- Pharmacy certification status check
- Program-specific ETASU requirement evaluation
- Distribution channel access validation
- Dispensing authorization workflow
Dispensing Documentation
Lab and monitoring integration
- Lab verification documentation (pregnancy/ANC/LFT)
- Monitoring requirement compliance tracking
- Patient counseling documentation
- Dispensing event documentation
- ETASU compliance audit trail
- FDA-inspection-ready documentation archive
Program Intelligence
FDA modification tracking
- FDA REMS program modification monitoring
- ETASU requirement update workflow
- Distribution channel access maintenance
- Prescriber certification renewal tracking
- Pharmacy certification renewal management
- Multi-program coordination across REMS portfolio
Financial impact
What REMS compliance discipline means in dollars?
Fast Results
Built for FDA Inspection Reality
Improvement Area
Estimated Annual Impact
REMS-Related Claim Rejection Reduction (14% → 1.8%)
$300K – $900K annually in recovered reimbursement
FDA Inspection Finding Prevention
$200K – $800K per inspection in prevented corrective action
Distribution Channel Access Protection
$150K – $500K annually in maintained patient access
ETASU Documentation Compliance
$100K – $400K annually in retained dispensing authority
Multi-Program Workflow Consolidation
$120K – $400K annually in operational efficiency
Prescriber Certification Renewal Tracking
$80K – $300K annually in maintained prescriber networks
Staffing Cost Reduction / Replacement
$120K – $300K annually
REMS compliance performance targets
Performance Metric
Industry Benchmark
AnnexMed Target
ETASU Documentation Compliance
Industry avg: 84–92%
100% target
REMS-Related Claim Rejection Rate
Industry avg: 10–18%
< 2%
Pre-Dispensing Enrollment Verification
Industry: often soft check
100%
FDA Inspection Findings
Industry varies widely
Zero target
Program Coverage
Most operations cover 2–4 programs
All active REMS programs
Distribution Channel Access
Industry: often lapses
Maintained across program portfolio
Prescriber Certification Tracking
Industry: variable
Standard
FDA Program Modification Currency
Industry standard: Annual review
Real-time monitoring
Why Annexmed?
Bolt-on REMS workflow vs. AnnexMed standing compliance discipline
In-House / Traditional
AnnexMed Partnership
Enrollment Verification
Soft check; dispensing often proceeds without verification
Hard pre-dispensing gate with verified enrollment, certification, and ETASU
ETASU Documentation
Generic specialty workflow; gaps accumulate
Program-specific ETASU documentation as standard workflow
Program Coverage
Top 2–4 programs; gaps elsewhere
All active REMS programs covered with program-specific protocols
Lab Integration
Manual coordination
Integrated lab verification documentation with dispensing timing alignment
FDA Modification Tracking
Annual review at best
Real-time FDA REMS program modification monitoring
Distribution Channel Maintenance
Often lapses without active management
Active maintenance across program portfolio
Inspection Readiness
Reactive documentation under inspection pressure
Continuous audit-ready documentation as byproduct of operations
Cost to Operate
$80K–$115K per FTE for REMS-aware specialist
30–40% lower with no hiring, attrition, or training overhead
Technology
Powered by proprietary AI & analytics
AnnexMed’s technology stack was built for payer-specific operational demands, not adapted from provider-side billing tools. Risk adjustment accuracy, payment integrity, and credentialing compliance each require different data models, workflow logic, and reporting architectures than provider RCM. Our platform reflects that.
AI Agents & Automation
AI Agents & Intelligent Automation deploys autonomous AI agents across the full revenue cycle, automating eligibility verification, prior authorization, claims processing, payment posting, and denial management at hospital scale and speed.
Data & Analytics Platform
Data & Analytics Platform delivers real-time Power BI dashboards built for hospital executive visibility, including system-wide KPIs, service line performance, payer analysis, productivity, financial forecasting, and national benchmarking insights.
Intelligent AR Management
Intelligent AR Management handles A/R follow-up at hospital scale with intelligent worklists prioritized by dollar value and aging, payer-specific follow-up rules, automated escalation for high-value accounts, and full accountability for every claim.
Computer Assisted Coding
Computer Assisted Coding orchestrates hospital coding operation, intelligent chart assignment by service line, TAT tracking with SLA monitoring, quality audits with accuracy scoring, and coder performance management at enterprise scale.
Together, these platforms create a fully instrumented RCM operation where nothing falls through the cracks. You don’t interact with these systems directly, but the results they enable show up directly in your financial performance.
Ready to make REMS compliance standing specialty pharmacy discipline?
Trusted by 100+ Healthcare Providers | AAPC, AHIMA & AAHAM Certified | SOC 2 Type II | HIPAA Compliant
Payer client outcomes
$15M–$40M
Risk
Adjustment
$18M–$50M
Payment
Integrity
6 Weeks
Credentialing Clearance
$15M–$50M+
Revenue
Impact
Case Studies
See the impact we deliver
Discover how AnnexMed reduces denials, accelerates reimbursements, and strengthens financial performance. Backed by measurable outcomes and proven RCM expertise, we deliver operational excellence, revenue stability, and sustainable growth you can trust.
Client Voices
See how our clients succeed
Proven RCM expertise. Delivered at scale.
For over 20 years, AnnexMed has delivered RCM solutions nationwide, combining expert billing, coding, and AR support to drive measurable results and growth.
- 20+ years of proven healthcare RCM experience
- 1,500+ professionals supporting billing, coding & AR
- 500+ certified coders across multiple specialties
- 99%+ compliance with HIPAA and security standards
- All 50 states served with consistent, scalable operations
